Small Molecules
16 October 2018
PolyPid Begins Phase 2 Study to Assess Safety and Efficacy of D-PLEX100 in Prevention of Abdominal Surgical Site Infections14 October 2018
BioPharmX Initiates Phase 2b Trial of BPX-04 for Rosacea14 October 2018
U.S. FDA approves Bayer’s Xarelto® for patients with coronary or peripheral artery disease14 October 2018
Positive Late-Breaking Phase II Data Evaluating Investigational Oral Therapy, Evobrutinib in RMS11 October 2018
Pharmaxis releases positive results of phase 1 clinical trial for LOXL2 inhibitor compound10 October 2018
Janssen Submits European Marketing Authorisation Application for Esketamine Nasal Spray for Treatment-Resistant Depression10 October 2018
Cantrixil Phase I Study Progresses To Next Stage10 October 2018
Celgene Announces Phase 3 STYLE Study of OTEZLA® (apremilast) in Moderate to Severe Scalp Psoriasis Met Primary Endpoint10 October 2018
REVOLUTION Medicines Announces First Patient Dosed with RMC-4630 in Phase 1 Clinical Study in Patients with Advanced Solid Tumors10 October 2018
NeuroVive Receives KL1333 Clinical Trial Regulatory Approval6 October 2018
Cavion Announces Promising Phase 2 Data for Essential Tremor in T-CALM Proof-of-Concept Study6 October 2018
Progenics Reports Results of Phase 2/3 Trial of PSMA PET Imaging Agent PyL for the Detection of Prostate CancerNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
SubscribeNewsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
SubscribeFeatured reports